American International Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-90,394
| Closed | -$16.6K | – | 3169 |
|
|
2021
Q2 | $16.6K | Sell |
90,394
-1,709
| -2% | -$293K | 0.06% | 281 |
|
|
2021
Q1 | $14.1K | Sell |
92,103
-2,303
| -2% | -$356K | 0.05% | 342 |
|
|
2020
Q4 | $14.8K | Sell |
94,406
-311
| -0.3% | -$40K | 0.05% | 293 |
|
|
2020
Q3 | $10.8M | Sell |
94,717
-3,643
| -4% | -$393K | 0.05% | 316 |
|
|
2020
Q2 | $11M | Buy |
98,360
+1,058
| +1% | +$112K | 0.05% | 297 |
|
|
2020
Q1 | $8.74M | Sell |
97,302
-1,056
| -1% | -$104K | 0.05% | 336 |
|
|
2019
Q4 | $10.6M | Buy |
98,358
+2,242
| +2% | +$240K | 0.04% | 399 |
|
|
2019
Q3 | $9.41M | Sell |
96,116
-490
| -0.5% | -$55.2K | 0.04% | 446 |
|
|
2019
Q2 | $12.7M | Sell |
96,606
-2,150
| -2% | -$277K | 0.05% | 291 |
|
|
2019
Q1 | $13.3M | Sell |
98,756
-394
| -0.4% | -$49K | 0.05% | 274 |
|
|
2018
Q4 | $9.65M | Sell |
99,150
-5,060
| -5% | -$598K | 0.04% | 349 |
|
|
2018
Q3 | $14.5M | Buy |
104,210
+5,079
| +5% | +$637K | 0.05% | 251 |
|
|
2018
Q2 | $12.3M | Buy |
99,131
+125
| +0.1% | +$14.6K | 0.04% | 282 |
|
|
2018
Q1 | $11M | Sell |
99,006
-1,890
| -2% | -$226K | 0.04% | 349 |
|
|
2017
Q4 | $12.1M | Buy |
100,896
+1,499
| +2% | +$183K | 0.04% | 325 |
|
|
2017
Q3 | $13.9M | Sell |
99,397
-4,124
| -4% | -$560K | 0.05% | 226 |
|
|
2017
Q2 | $12.6M | Buy |
103,521
+1,015
| +1% | +$118K | 0.04% | 253 |
|
|
2017
Q1 | $12.4M | Buy |
102,506
+268
| +0.3% | +$34.6K | 0.05% | 263 |
|
|
2016
Q4 | $12.5M | Sell |
102,238
-1,433
| -1% | -$175K | 0.05% | 246 |
|
|
2016
Q3 | $12.7M | Buy |
103,671
+795
| +0.8% | +$102K | 0.05% | 215 |
|
|
2016
Q2 | $12M | Buy |
102,876
+6,029
| +6% | +$855K | 0.05% | 224 |
|
|
2016
Q1 | $13.5M | Sell |
96,847
-1,294
| -1% | -$190K | 0.05% | 226 |
|
|
2015
Q4 | $18.7M | Buy |
98,141
+1,203
| +1% | +$210K | 0.08% | 146 |
|
|
2015
Q3 | $15.2M | Buy |
96,938
+859
| +0.9% | +$157K | 0.07% | 173 |
|
|
2015
Q2 | $17.4M | Buy |
96,079
+6,394
| +7% | +$1.1M | 0.07% | 168 |
|
|
2015
Q1 | $15.5M | Buy |
89,685
+4,814
| +6% | +$871K | 0.06% | 198 |
|
|
2014
Q4 | $15.7M | Sell |
84,871
-1,199
| -1% | -$222K | 0.07% | 176 |
|
|
2014
Q3 | $14.3M | Buy |
86,070
+1,300
| +2% | +$213K | 0.06% | 196 |
|
|
2014
Q2 | $13.2M | Sell |
84,770
-5,412
| -6% | -$855K | 0.06% | 234 |
|
|
2014
Q1 | $13.7M | Sell |
90,182
-896
| -1% | -$142K | 0.06% | 197 |
|
|
2013
Q4 | $12.1M | Sell |
91,078
-454
| -0.5% | -$54.5K | 0.06% | 226 |
|
|
2013
Q3 | $10.6M | Buy |
91,532
+2,844
| +3% | +$312K | 0.06% | 264 |
|
|
2013
Q2 | $8.18M | Buy |
+88,688
| New | +$8.55M | 0.05% | 361 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM